Objective: To examine attitudes and beliefs associated with changes in the
intention to use benzodiazepines during the six-month period after first be
nzodiazepine use.
Design: Population-based 6-month follow-up with 3 measurement points (basel
ine, 2 weeks after inclusion, 6 months after inclusion).
Setting: Starting or initial benzodiazepine users were included during a pe
riod of 4 months from November 1994 in the only pharmacy of a Dutch communi
ty of 13,500 people.
Measures: Variables proposed by the Model of Planned Behaviour and the Heal
th Belief Model. Drug exposure data from automated pharmacy records.
Results: At baseline, the intention to use benzodiazepines was primarily pr
edicted by the perceived norm of the general practitioner regarding benzodi
azepine use, and by the participants' own attitudes. After fourteen days, t
he determinants of change in the intention to use benzodiazepines were the
initially perceived norm of the general practitioner and the change in the
severity of participants' illnesses. After six months, the change in the se
verity of the illness and the perceived health benefits of benzodiazepines
at the time of inclusion were the main determinants of the change in the in
tention to use benzodiazepines between the second and third measurement poi
nt. The intention to use benzodiazepines showed a decrease during follow-up
. The three intention measures were significant predictors of actual benzod
iazepine use during the year following baseline assessment.
Conclusion: The study sheds light on interesting determinants of decrease o
r increase in the intention to use during the six-month period after first
benzodiazepine use.